Reference: FLCCC Alliance. (2021). I-MASK+ prophylaxis & early outpatient treatment protocol for COVID-19. Retrieved from www.flccc.net Summary: The FLCCC Alliance’s I-MASK+ protocol provides guidelines for the prophylaxis and early outpatient treatment of COVID-19. It recommends the use of Ivermectin, along with Vitamin D3, Vitamin C, Quercetin, Zinc, Melatonin, and Aspirin for high-risk individuals and post-exposure […]
Reference: McCullough, P. A., Alexander, P. E., Armstrong, R., Arvinte, C., Bain, A. F., Bartlett, R. P., … & Zelenko, V. (2020). Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Reviews in Cardiovascular Medicine, 21(4), 517–530. https://doi.org/10.31083/j.rcm.2020.04.264 Summary: The article discusses a comprehensive approach to treat early ambulatory high-risk COVID-19
Reference: Informed Consent Action Network. (2022). V-safe data. https://icandecide.org/v-safe-data/#v-safe-downloads Summary: The V-Safe Data report from the Informed Consent Action Network (ICAN) presents comprehensive statistics on adverse health impacts following COVID-19 vaccinations. The data indicates that over 10 million individuals registered on the V-Safe platform, with significant health impacts reported, totalling approximately 6.4 million. The report
Reference: Bruno, R., McCullough, P., et al. (2021). 157 Top Scientists and Doctors Release Shocking Study on COVID Vaccines and Demand Immediate Stop to All Vaccinations. Global Research. Summary: A report by 57 prominent scientists and doctors has raised significant concerns about the safety and efficacy of COVID-19 vaccines, urging an immediate cessation of vaccination
Reference: Kory, P., Meduri, G. U., Varon, J., Iglesias, J., & Marik, P. E. (2021). Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. American Journal of Therapeutics, 28(3), e299–e318. https://doi.org/10.1097/MJT.0000000000001163 Summary: This article reviews evidence supporting ivermectin as an effective treatment and prophylactic agent for COVID-19.
Reference: General patient consent form for pharmacies during 2021. Summary: General consent form drawn up for pharmacies dispensing Ivermecting to patients during 2021. DOWNLOAD
Reference: McGee, S., & De Waal, R. (2020). Rapid review of remdesivir for COVID-19: Update 15 December 2020. South African National Department of Health. Summary: The South African National Department of Health conducted a rapid review of remdesivir’s efficacy for treating hospitalised COVID-19 patients. The analysis included five randomised controlled trials (RCTs) with over 7,700
Reference: Tang, M., Hu, X., Wang, Y., Yao, X., Zhang, W., Yu, C., Cheng, F., Li, J., & Fang, Q. (2021). Ivermectin, a potential anticancer drug derived from an antiparasitic drug. Pharmacological Research, 163, 105207. https://doi.org/10.1016/j.phrs.2020.105207 Summary: Since January 2020, Elsevier has provided a COVID-19 resource centre offering free access to research on the virus,
Reference: Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020). Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis. The Lancet, published online May 22, https://doi.org/10.1016/S0140-6736(20)31180-6 Summary: In June 2020, The Lancet announced the retraction of a significant study assessing the effectiveness of hydroxychloroquine
Reference: Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020). Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis. The Lancet, 395(10240), 1820-1830. https://doi.org/10.1016/S0140-6736(20)31180-6 Summary: The study evaluates the efficacy of hydroxychloroquine and chloroquine, either alone or in combination with macrolides, in treating COVID-19